APO Research
Talk to an analyst

APO RESEARCH · REPORT

Onychomycosis (Tinea Unguium) Drug

Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.

Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease.

Selected research

Industry Growth & Trends

Global Onychomycosis (Tinea Unguium) Drug Industry Growth and Trends Forecast to 2032

21 December 2025112 pages

Choose your research edition.

Industry ResearchOnychomycosis (Tinea Unguium) Drug Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Onychomycosis (Tinea Unguium) Drug Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Onychomycosis (Tinea Unguium) Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Onychomycosis (Tinea Unguium) Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Onychomycosis (Tinea Unguium) Drug Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.

Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease.

According to APO Research, the global Onychomycosis (Tinea Unguium) Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Onychomycosis (Tinea Unguium) Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Onychomycosis (Tinea Unguium) Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Onychomycosis (Tinea Unguium) Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Onychomycosis (Tinea Unguium) Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Onychomycosis (Tinea Unguium) Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Onychomycosis (Tinea Unguium) Drug Market by Company

Pfizer

Yangtze River

Torrent Pharma

J&J

Chengdu Brilliant

Novartis

Qilu Pharmaceutical

Xiuzheng Pharmaceutical

Hubei Hengan

TARO

Perrigo

Galderma pharm

Zhejiang Deyer

Valeant Pharma

Moberg

Onychomycosis (Tinea Unguium) Drug Segment by Type

Oral Medication

External Medicine

Onychomycosis (Tinea Unguium) Drug Segment by Application

Age under 18

Age 18-50

Age above 50

Onychomycosis (Tinea Unguium) Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Onychomycosis (Tinea Unguium) Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Onychomycosis (Tinea Unguium) Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Onychomycosis (Tinea Unguium) Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Onychomycosis (Tinea Unguium) Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Onychomycosis (Tinea Unguium) Drug Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Onychomycosis (Tinea Unguium) Drug Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Onychomycosis (Tinea Unguium) Drug Market Share by Region (2021-2026) Table 4. Global Onychomycosis (Tinea Unguium) Drug Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Onychomycosis (Tinea Unguium) Drug Market Share by Region (2027-2032) Table 6. Global Onychomycosis (Tinea Unguium) Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Onychomycosis (Tinea Unguium) Drug Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Onychomycosis (Tinea Unguium) Drug Market Size Share by Type (2021-2026) Table 9. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Onychomycosis (Tinea Unguium) Drug Market Size Share Forecasted by Type (2027-2032) Table 11. North America Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Onychomycosis (Tinea Unguium) Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Onychomycosis (Tinea Unguium) Drug Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Onychomycosis (Tinea Unguium) Drug Market Size Share by Application (2021-2026) Table 24. Global Onychomycosis (Tinea Unguium) Drug Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Onychomycosis (Tinea Unguium) Drug Market Size Share Forecasted by Application (2027-2032) Table 26. North America Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Onychomycosis (Tinea Unguium) Drug Industry Trends Table 37. Onychomycosis (Tinea Unguium) Drug Industry Drivers Table 38. Onychomycosis (Tinea Unguium) Drug Industry Opportunities and Challenges Table 39. Onychomycosis (Tinea Unguium) Drug Industry Restraints Table 40. Global Onychomycosis (Tinea Unguium) Drug Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Company (2021-2026) Table 42. Global Onychomycosis (Tinea Unguium) Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Onychomycosis (Tinea Unguium) Drug Key Company Headquarters & Area Served Table 44. Global Onychomycosis (Tinea Unguium) Drug Company, Product Type & Application Table 45. Global Onychomycosis (Tinea Unguium) Drug Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Onychomycosis (Tinea Unguium) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Pfizer Company Information Table 49. Pfizer Business Overview Table 50. Pfizer Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Pfizer Onychomycosis (Tinea Unguium) Drug Product Portfolio Table 52. Pfizer Recent Development Table 53. Yangtze River Company Information Table 54. Yangtze River Business Overview Table 55. Yangtze River Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Yangtze River Onychomycosis (Tinea Unguium) Drug Product Portfolio Table 57. Yangtze River Recent Development Table 58. Torrent Pharma Company Information Table 59. Torrent Pharma Business Overview Table 60. Torrent Pharma Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product Portfolio Table 62. Torrent Pharma Recent Development Table 63. J&J Company Information Table 64. J&J Business Overview Table 65. J&J Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. J&J Onychomycosis (Tinea Unguium) Drug Product Portfolio Table 67. J&J Recent Development Table 68. Chengdu Brilliant Company Information Table 69. Chengdu Brilliant Business Overview Table 70. Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product Portfolio Table 72. Chengdu Brilliant Recent Development Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Novartis Onychomycosis (Tinea Unguium) Drug Product Portfolio Table 77. Novartis Recent Development Table 78. Qilu Pharmaceutical Company Information Table 79. Qilu Pharmaceutical Business Overview Table 80. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio Table 82. Qilu Pharmaceutical Recent Development Table 83. Xiuzheng Pharmaceutical Company Information Table 84. Xiuzheng Pharmaceutical Business Overview Table 85. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio Table 87. Xiuzheng Pharmaceutical Recent Development Table 88. Hubei Hengan Company Information Table 89. Hubei Hengan Business Overview Table 90. Hubei Hengan Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product Portfolio Table 92. Hubei Hengan Recent Development Table 93. TARO Company Information Table 94. TARO Business Overview Table 95. TARO Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. TARO Onychomycosis (Tinea Unguium) Drug Product Portfolio Table 97. TARO Recent Development Table 98. Perrigo Company Information Table 99. Perrigo Business Overview Table 100. Perrigo Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Perrigo Onychomycosis (Tinea Unguium) Drug Product Portfolio Table 102. Perrigo Recent Development Table 103. Galderma pharm Company Information Table 104. Galderma pharm Business Overview Table 105. Galderma pharm Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Galderma pharm Onychomycosis (Tinea Unguium) Drug Product Portfolio Table 107. Galderma pharm Recent Development Table 108. Zhejiang Deyer Company Information Table 109. Zhejiang Deyer Business Overview Table 110. Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product Portfolio Table 112. Zhejiang Deyer Recent Development Table 113. Valeant Pharma Company Information Table 114. Valeant Pharma Business Overview Table 115. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Portfolio Table 117. Valeant Pharma Recent Development Table 118. Moberg Company Information Table 119. Moberg Business Overview Table 120. Moberg Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Moberg Onychomycosis (Tinea Unguium) Drug Product Portfolio Table 122. Moberg Recent Development Table 123. North America Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Onychomycosis (Tinea Unguium) Drug Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Onychomycosis (Tinea Unguium) Drug Market Share by Country (2021-2026) Table 126. North America Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Country (2027-2032) Table 128. Europe Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Onychomycosis (Tinea Unguium) Drug Market Share by Country (2021-2026) Table 131. Europe Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Share by Country (2021-2026) Table 136. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Country (2027-2032) Table 138. Latin America Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Onychomycosis (Tinea Unguium) Drug Market Share by Country (2021-2026) Table 141. Latin America Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Share by Country (2021-2026) Table 146. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Onychomycosis (Tinea Unguium) Drug Product Image Figure 3. Global Onychomycosis (Tinea Unguium) Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Onychomycosis (Tinea Unguium) Drug Market Size (2021-2032) & (US$ Million) Figure 5. Global Onychomycosis (Tinea Unguium) Drug Market Share by Region: 2025 VS 2032 Figure 6. Global Onychomycosis (Tinea Unguium) Drug Market Share by Region (2021-2032) Figure 7. North America Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Oral Medication Image Figure 13. Global Oral Medication Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. External Medicine Image Figure 15. Global External Medicine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Onychomycosis (Tinea Unguium) Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Onychomycosis (Tinea Unguium) Drug Market Share by Type 2025 VS 2032 Figure 18. North America Onychomycosis (Tinea Unguium) Drug Market Size Share by Type (2021-2032) Figure 19. Europe Onychomycosis (Tinea Unguium) Drug Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size Share by Type (2021-2032) Figure 21. Latin America Onychomycosis (Tinea Unguium) Drug Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size Share by Type (2021-2032) Figure 23. Age under 18 Image Figure 24. Global Age under 18 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Age 18-50 Image Figure 26. Global Age 18-50 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Age above 50 Image Figure 28. Global Age above 50 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Onychomycosis (Tinea Unguium) Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Onychomycosis (Tinea Unguium) Drug Market Share by Application 2025 VS 2032 Figure 31. North America Onychomycosis (Tinea Unguium) Drug Market Size Share by Application (2021-2032) Figure 32. Europe Onychomycosis (Tinea Unguium) Drug Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size Share by Application (2021-2032) Figure 34. Latin America Onychomycosis (Tinea Unguium) Drug Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Onychomycosis (Tinea Unguium) Drug Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Onychomycosis (Tinea Unguium) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Onychomycosis (Tinea Unguium) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Onychomycosis (Tinea Unguium) Drug Market Share by Country (2021-2032) Figure 41. Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Onychomycosis (Tinea Unguium) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Onychomycosis (Tinea Unguium) Drug Market Share by Country (2021-2032) Figure 44. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Share by Country (2021-2032) Figure 47. Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Onychomycosis (Tinea Unguium) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Onychomycosis (Tinea Unguium) Drug Market Share by Country (2021-2032) Figure 50. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Medication
  • External Medicine
Applications
  • Age under 18
  • Age 18-50
  • Age above 50
Companies covered
  • Pfizer
  • Yangtze River
  • Torrent Pharma
  • J&J
  • Chengdu Brilliant
  • Novartis
  • Qilu Pharmaceutical
  • Xiuzheng Pharmaceutical
  • Hubei Hengan
  • TARO
  • Perrigo
  • Galderma pharm
  • Zhejiang Deyer
  • Valeant Pharma
  • Moberg

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Onychomycosis (Tinea Unguium) Drug Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Onychomycosis (Tinea Unguium) Drug Market Size by Region (2021-2032)
  5. 1.4.1 Global Onychomycosis (Tinea Unguium) Drug Market Size by Region (2021-2026)
  6. 1.4.2 Global Onychomycosis (Tinea Unguium) Drug Market Size by Region (2027-2032)
  7. 1.5 Key Regions Onychomycosis (Tinea Unguium) Drug Market Size (2021-2032)
  8. 1.5.1 North America Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate (2021-2032)
2 Onychomycosis (Tinea Unguium) Drug Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Oral Medication
  3. 2.1.2 External Medicine
  4. 2.2 Global Onychomycosis (Tinea Unguium) Drug Market Size by Type
  5. 2.2.1 Global Onychomycosis (Tinea Unguium) Drug Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Onychomycosis (Tinea Unguium) Drug Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Onychomycosis (Tinea Unguium) Drug Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Onychomycosis (Tinea Unguium) Drug Market Size by Regions
  9. 2.3.1 North America Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Type (2021-2026)
3 Onychomycosis (Tinea Unguium) Drug Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Age under 18
  3. 3.1.2 Age 18-50
  4. 3.1.3 Age above 50
  5. 3.2 Global Onychomycosis (Tinea Unguium) Drug Market Size by Application
  6. 3.2.1 Global Onychomycosis (Tinea Unguium) Drug Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Onychomycosis (Tinea Unguium) Drug Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Onychomycosis (Tinea Unguium) Drug Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Onychomycosis (Tinea Unguium) Drug Market Size by Regions
  10. 3.3.1 North America Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Onychomycosis (Tinea Unguium) Drug Industry Trends
  2. 4.2 Onychomycosis (Tinea Unguium) Drug Industry Drivers
  3. 4.3 Onychomycosis (Tinea Unguium) Drug Industry Opportunities and Challenges
  4. 4.4 Onychomycosis (Tinea Unguium) Drug Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Onychomycosis (Tinea Unguium) Drug Revenue (2021-2026)
  2. 5.2 Global Onychomycosis (Tinea Unguium) Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Onychomycosis (Tinea Unguium) Drug Key Company Headquarters & Area Served
  4. 5.4 Global Onychomycosis (Tinea Unguium) Drug Company, Product Type & Application
  5. 5.5 Global Onychomycosis (Tinea Unguium) Drug Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Onychomycosis (Tinea Unguium) Drug Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Onychomycosis (Tinea Unguium) Drug Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Onychomycosis (Tinea Unguium) Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Pfizer
  2. 6.1.1 Pfizer Company Information
  3. 6.1.2 Pfizer Business Overview
  4. 6.1.3 Pfizer Onychomycosis (Tinea Unguium) Drug Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer Onychomycosis (Tinea Unguium) Drug Product Portfolio
  6. 6.1.5 Pfizer Recent Developments
  7. 6.2 Yangtze River
  8. 6.2.1 Yangtze River Company Information
  9. 6.2.2 Yangtze River Business Overview
  10. 6.2.3 Yangtze River Onychomycosis (Tinea Unguium) Drug Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Yangtze River Onychomycosis (Tinea Unguium) Drug Product Portfolio
  12. 6.2.5 Yangtze River Recent Developments
  13. 6.3 Torrent Pharma
  14. 6.3.1 Torrent Pharma Company Information
  15. 6.3.2 Torrent Pharma Business Overview
  16. 6.3.3 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product Portfolio
  18. 6.3.5 Torrent Pharma Recent Developments
  19. 6.4 J&J
  20. 6.4.1 J&J Company Information
  21. 6.4.2 J&J Business Overview
  22. 6.4.3 J&J Onychomycosis (Tinea Unguium) Drug Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 J&J Onychomycosis (Tinea Unguium) Drug Product Portfolio
  24. 6.4.5 J&J Recent Developments
  25. 6.5 Chengdu Brilliant
  26. 6.5.1 Chengdu Brilliant Company Information
  27. 6.5.2 Chengdu Brilliant Business Overview
  28. 6.5.3 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product Portfolio
  30. 6.5.5 Chengdu Brilliant Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Onychomycosis (Tinea Unguium) Drug Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Novartis Onychomycosis (Tinea Unguium) Drug Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Qilu Pharmaceutical
  38. 6.7.1 Qilu Pharmaceutical Company Information
  39. 6.7.2 Qilu Pharmaceutical Business Overview
  40. 6.7.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio
  42. 6.7.5 Qilu Pharmaceutical Recent Developments
  43. 6.8 Xiuzheng Pharmaceutical
  44. 6.8.1 Xiuzheng Pharmaceutical Company Information
  45. 6.8.2 Xiuzheng Pharmaceutical Business Overview
  46. 6.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio
  48. 6.8.5 Xiuzheng Pharmaceutical Recent Developments
  49. 6.9 Hubei Hengan
  50. 6.9.1 Hubei Hengan Company Information
  51. 6.9.2 Hubei Hengan Business Overview
  52. 6.9.3 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product Portfolio
  54. 6.9.5 Hubei Hengan Recent Developments
  55. 6.10 TARO
  56. 6.10.1 TARO Company Information
  57. 6.10.2 TARO Business Overview
  58. 6.10.3 TARO Onychomycosis (Tinea Unguium) Drug Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 TARO Onychomycosis (Tinea Unguium) Drug Product Portfolio
  60. 6.10.5 TARO Recent Developments
  61. 6.11 Perrigo
  62. 6.11.1 Perrigo Company Information
  63. 6.11.2 Perrigo Business Overview
  64. 6.11.3 Perrigo Onychomycosis (Tinea Unguium) Drug Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Perrigo Onychomycosis (Tinea Unguium) Drug Product Portfolio
  66. 6.11.5 Perrigo Recent Developments
  67. 6.12 Galderma pharm
  68. 6.12.1 Galderma pharm Company Information
  69. 6.12.2 Galderma pharm Business Overview
  70. 6.12.3 Galderma pharm Onychomycosis (Tinea Unguium) Drug Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Galderma pharm Onychomycosis (Tinea Unguium) Drug Product Portfolio
  72. 6.12.5 Galderma pharm Recent Developments
  73. 6.13 Zhejiang Deyer
  74. 6.13.1 Zhejiang Deyer Company Information
  75. 6.13.2 Zhejiang Deyer Business Overview
  76. 6.13.3 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product Portfolio
  78. 6.13.5 Zhejiang Deyer Recent Developments
  79. 6.14 Valeant Pharma
  80. 6.14.1 Valeant Pharma Company Information
  81. 6.14.2 Valeant Pharma Business Overview
  82. 6.14.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Portfolio
  84. 6.14.5 Valeant Pharma Recent Developments
  85. 6.15 Moberg
  86. 6.15.1 Moberg Company Information
  87. 6.15.2 Moberg Business Overview
  88. 6.15.3 Moberg Onychomycosis (Tinea Unguium) Drug Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Moberg Onychomycosis (Tinea Unguium) Drug Product Portfolio
  90. 6.15.5 Moberg Recent Developments
7 North America
  1. 7.1 North America Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Onychomycosis (Tinea Unguium) Drug Market Size by Country (2021-2026)
  3. 7.3 North America Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country (2021-2026)
  3. 8.3 Europe Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Onychomycosis (Tinea Unguium) Drug Market Size by Country (2021-2026)
  3. 10.3 South America Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst